VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,593,000 | -46.9% | 162,848 | -52.2% | 0.08% | -50.0% |
| Q3 2017 | $4,882,000 | -17.2% | 340,679 | 0.0% | 0.17% | -22.4% |
| Q2 2017 | $5,894,000 | +386.7% | 340,679 | +210.4% | 0.21% | +375.6% |
| Q1 2017 | $1,211,000 | -24.0% | 109,769 | 0.0% | 0.04% | -29.7% |
| Q4 2016 | $1,594,000 | -40.9% | 109,769 | 0.0% | 0.06% | -40.2% |
| Q3 2016 | $2,695,000 | +21.9% | 109,769 | 0.0% | 0.11% | +17.6% |
| Q2 2016 | $2,211,000 | +59.9% | 109,769 | +108.7% | 0.09% | +56.9% |
| Q1 2016 | $1,383,000 | – | 52,599 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |